Carregant...
The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps
Biologic therapy is a new treatment option for patients with chronic rhinosinusitis with nasal polyps (CRSwNP). Currently, the only biologic with Food and Drug Administration–approval status for CRSwNP is dupilumab. Several other biologics are likely to be approved for CRSwNP, including mepolizumab...
Guardat en:
| Publicat a: | Ear Nose Throat J |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7980424/ https://ncbi.nlm.nih.gov/pubmed/33035132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0145561320964653 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|